The global CRISPR Gene Testing and Diagnostics market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
We have surveyed the CRISPR Gene Testing and Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for CRISPR Gene Testing and Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR Gene Testing and Diagnostics. This report contains market size and forecasts of CRISPR Gene Testing and Diagnostics in global, including the following market information:
Global CRISPR Gene Testing and Diagnostics market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five CRISPR Gene Testing and Diagnostics companies in 2024 (%)
Total Market by Segment:
Global CRISPR Gene Testing and Diagnostics market, by Type, 2020-2025, 2026-2032 ($ millions)
Global CRISPR Gene Testing and Diagnostics market segment percentages, by Type, 2024 (%)
Animals
Plants
Pathogens
Others
Global CRISPR Gene Testing and Diagnostics market, by Application, 2020-2025, 2026-2032 ($ millions)
Global CRISPR Gene Testing and Diagnostics market segment percentages, by Application, 2024 (%)
Medical Industry
Agriculture
Others
Global CRISPR Gene Testing and Diagnostics market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global CRISPR Gene Testing and Diagnostics market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies CRISPR Gene Testing and Diagnostics revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies CRISPR Gene Testing and Diagnostics revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
10x Genomics
Aelian Biotechnology
Agilent Technologies
Axxam
Beckman Coulter
Becton, Dickinson and Company
Binx Health
bioM�rieux
Bio-Rad Laboratories
Caspr Biotech
ERS Genomics
FASMAC
Illumina
Janssen Diagnostics
Locus Biosciences
Mammoth Biosciences
NRGene
Roche
Sherlock Biosciences
Thermo Fisher Scientific
Vivlion
Outline of Major Chapters:
Chapter 1: Introduces the definition of CRISPR Gene Testing and Diagnostics, market overview.
Chapter 2: Global CRISPR Gene Testing and Diagnostics market size in revenue.
Chapter 3: Detailed analysis of CRISPR Gene Testing and Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of CRISPR Gene Testing and Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 CRISPR Gene Testing and Diagnostics Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global CRISPR Gene Testing and Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CRISPR Gene Testing and Diagnostics Overall Market Size
2.1 Global CRISPR Gene Testing and Diagnostics Market Size: 2024 VS 2032
2.2 Global CRISPR Gene Testing and Diagnostics Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top CRISPR Gene Testing and Diagnostics Players in Global Market
3.2 Top Global CRISPR Gene Testing and Diagnostics Companies Ranked by Revenue
3.3 Global CRISPR Gene Testing and Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 CRISPR Gene Testing and Diagnostics Companies in Global Market, by Revenue in 2024
3.5 Global Companies CRISPR Gene Testing and Diagnostics Product Type
3.6 Tier 1, Tier 2, and Tier 3 CRISPR Gene Testing and Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 CRISPR Gene Testing and Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 CRISPR Gene Testing and Diagnostics Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global CRISPR Gene Testing and Diagnostics Market Size Markets, 2024 & 2032
4.1.2 Animals
4.1.3 Plants
4.1.4 Pathogens
4.1.5 Others
4.2 Segmentation by Type - Global CRISPR Gene Testing and Diagnostics Revenue & Forecasts
4.2.1 Segmentation by Type - Global CRISPR Gene Testing and Diagnostics Revenue, 2020-2025
4.2.2 Segmentation by Type - Global CRISPR Gene Testing and Diagnostics Revenue, 2026-2032
4.2.3 Segmentation by Type - Global CRISPR Gene Testing and Diagnostics Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global CRISPR Gene Testing and Diagnostics Market Size, 2024 & 2032
5.1.2 Medical Industry
5.1.3 Agriculture
5.1.4 Others
5.2 Segmentation by Application - Global CRISPR Gene Testing and Diagnostics Revenue & Forecasts
5.2.1 Segmentation by Application - Global CRISPR Gene Testing and Diagnostics Revenue, 2020-2025
5.2.2 Segmentation by Application - Global CRISPR Gene Testing and Diagnostics Revenue, 2026-2032
5.2.3 Segmentation by Application - Global CRISPR Gene Testing and Diagnostics Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global CRISPR Gene Testing and Diagnostics Market Size, 2024 & 2032
6.2 By Region - Global CRISPR Gene Testing and Diagnostics Revenue & Forecasts
6.2.1 By Region - Global CRISPR Gene Testing and Diagnostics Revenue, 2020-2025
6.2.2 By Region - Global CRISPR Gene Testing and Diagnostics Revenue, 2026-2032
6.2.3 By Region - Global CRISPR Gene Testing and Diagnostics Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America CRISPR Gene Testing and Diagnostics Revenue, 2020-2032
6.3.2 United States CRISPR Gene Testing and Diagnostics Market Size, 2020-2032
6.3.3 Canada CRISPR Gene Testing and Diagnostics Market Size, 2020-2032
6.3.4 Mexico CRISPR Gene Testing and Diagnostics Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe CRISPR Gene Testing and Diagnostics Revenue, 2020-2032
6.4.2 Germany CRISPR Gene Testing and Diagnostics Market Size, 2020-2032
6.4.3 France CRISPR Gene Testing and Diagnostics Market Size, 2020-2032
6.4.4 U.K. CRISPR Gene Testing and Diagnostics Market Size, 2020-2032
6.4.5 Italy CRISPR Gene Testing and Diagnostics Market Size, 2020-2032
6.4.6 Russia CRISPR Gene Testing and Diagnostics Market Size, 2020-2032
6.4.7 Nordic Countries CRISPR Gene Testing and Diagnostics Market Size, 2020-2032
6.4.8 Benelux CRISPR Gene Testing and Diagnostics Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia CRISPR Gene Testing and Diagnostics Revenue, 2020-2032
6.5.2 China CRISPR Gene Testing and Diagnostics Market Size, 2020-2032
6.5.3 Japan CRISPR Gene Testing and Diagnostics Market Size, 2020-2032
6.5.4 South Korea CRISPR Gene Testing and Diagnostics Market Size, 2020-2032
6.5.5 Southeast Asia CRISPR Gene Testing and Diagnostics Market Size, 2020-2032
6.5.6 India CRISPR Gene Testing and Diagnostics Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America CRISPR Gene Testing and Diagnostics Revenue, 2020-2032
6.6.2 Brazil CRISPR Gene Testing and Diagnostics Market Size, 2020-2032
6.6.3 Argentina CRISPR Gene Testing and Diagnostics Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa CRISPR Gene Testing and Diagnostics Revenue, 2020-2032
6.7.2 Turkey CRISPR Gene Testing and Diagnostics Market Size, 2020-2032
6.7.3 Israel CRISPR Gene Testing and Diagnostics Market Size, 2020-2032
6.7.4 Saudi Arabia CRISPR Gene Testing and Diagnostics Market Size, 2020-2032
6.7.5 UAE CRISPR Gene Testing and Diagnostics Market Size, 2020-2032
7 Companies Profiles
7.1 10x Genomics
7.1.1 10x Genomics Corporate Summary
7.1.2 10x Genomics Business Overview
7.1.3 10x Genomics CRISPR Gene Testing and Diagnostics Major Product Offerings
7.1.4 10x Genomics CRISPR Gene Testing and Diagnostics Revenue in Global Market (2020-2025)
7.1.5 10x Genomics Key News & Latest Developments
7.2 Aelian Biotechnology
7.2.1 Aelian Biotechnology Corporate Summary
7.2.2 Aelian Biotechnology Business Overview
7.2.3 Aelian Biotechnology CRISPR Gene Testing and Diagnostics Major Product Offerings
7.2.4 Aelian Biotechnology CRISPR Gene Testing and Diagnostics Revenue in Global Market (2020-2025)
7.2.5 Aelian Biotechnology Key News & Latest Developments
7.3 Agilent Technologies
7.3.1 Agilent Technologies Corporate Summary
7.3.2 Agilent Technologies Business Overview
7.3.3 Agilent Technologies CRISPR Gene Testing and Diagnostics Major Product Offerings
7.3.4 Agilent Technologies CRISPR Gene Testing and Diagnostics Revenue in Global Market (2020-2025)
7.3.5 Agilent Technologies Key News & Latest Developments
7.4 Axxam
7.4.1 Axxam Corporate Summary
7.4.2 Axxam Business Overview
7.4.3 Axxam CRISPR Gene Testing and Diagnostics Major Product Offerings
7.4.4 Axxam CRISPR Gene Testing and Diagnostics Revenue in Global Market (2020-2025)
7.4.5 Axxam Key News & Latest Developments
7.5 Beckman Coulter
7.5.1 Beckman Coulter Corporate Summary
7.5.2 Beckman Coulter Business Overview
7.5.3 Beckman Coulter CRISPR Gene Testing and Diagnostics Major Product Offerings
7.5.4 Beckman Coulter CRISPR Gene Testing and Diagnostics Revenue in Global Market (2020-2025)
7.5.5 Beckman Coulter Key News & Latest Developments
7.6 Becton, Dickinson and Company
7.6.1 Becton, Dickinson and Company Corporate Summary
7.6.2 Becton, Dickinson and Company Business Overview
7.6.3 Becton, Dickinson and Company CRISPR Gene Testing and Diagnostics Major Product Offerings
7.6.4 Becton, Dickinson and Company CRISPR Gene Testing and Diagnostics Revenue in Global Market (2020-2025)
7.6.5 Becton, Dickinson and Company Key News & Latest Developments
7.7 Binx Health
7.7.1 Binx Health Corporate Summary
7.7.2 Binx Health Business Overview
7.7.3 Binx Health CRISPR Gene Testing and Diagnostics Major Product Offerings
7.7.4 Binx Health CRISPR Gene Testing and Diagnostics Revenue in Global Market (2020-2025)
7.7.5 Binx Health Key News & Latest Developments
7.8 bioM�rieux
7.8.1 bioM�rieux Corporate Summary
7.8.2 bioM�rieux Business Overview
7.8.3 bioM�rieux CRISPR Gene Testing and Diagnostics Major Product Offerings
7.8.4 bioM�rieux CRISPR Gene Testing and Diagnostics Revenue in Global Market (2020-2025)
7.8.5 bioM�rieux Key News & Latest Developments
7.9 Bio-Rad Laboratories
7.9.1 Bio-Rad Laboratories Corporate Summary
7.9.2 Bio-Rad Laboratories Business Overview
7.9.3 Bio-Rad Laboratories CRISPR Gene Testing and Diagnostics Major Product Offerings
7.9.4 Bio-Rad Laboratories CRISPR Gene Testing and Diagnostics Revenue in Global Market (2020-2025)
7.9.5 Bio-Rad Laboratories Key News & Latest Developments
7.10 Caspr Biotech
7.10.1 Caspr Biotech Corporate Summary
7.10.2 Caspr Biotech Business Overview
7.10.3 Caspr Biotech CRISPR Gene Testing and Diagnostics Major Product Offerings
7.10.4 Caspr Biotech CRISPR Gene Testing and Diagnostics Revenue in Global Market (2020-2025)
7.10.5 Caspr Biotech Key News & Latest Developments
7.11 ERS Genomics
7.11.1 ERS Genomics Corporate Summary
7.11.2 ERS Genomics Business Overview
7.11.3 ERS Genomics CRISPR Gene Testing and Diagnostics Major Product Offerings
7.11.4 ERS Genomics CRISPR Gene Testing and Diagnostics Revenue in Global Market (2020-2025)
7.11.5 ERS Genomics Key News & Latest Developments
7.12 FASMAC
7.12.1 FASMAC Corporate Summary
7.12.2 FASMAC Business Overview
7.12.3 FASMAC CRISPR Gene Testing and Diagnostics Major Product Offerings
7.12.4 FASMAC CRISPR Gene Testing and Diagnostics Revenue in Global Market (2020-2025)
7.12.5 FASMAC Key News & Latest Developments
7.13 Illumina
7.13.1 Illumina Corporate Summary
7.13.2 Illumina Business Overview
7.13.3 Illumina CRISPR Gene Testing and Diagnostics Major Product Offerings
7.13.4 Illumina CRISPR Gene Testing and Diagnostics Revenue in Global Market (2020-2025)
7.13.5 Illumina Key News & Latest Developments
7.14 Janssen Diagnostics
7.14.1 Janssen Diagnostics Corporate Summary
7.14.2 Janssen Diagnostics Business Overview
7.14.3 Janssen Diagnostics CRISPR Gene Testing and Diagnostics Major Product Offerings
7.14.4 Janssen Diagnostics CRISPR Gene Testing and Diagnostics Revenue in Global Market (2020-2025)
7.14.5 Janssen Diagnostics Key News & Latest Developments
7.15 Locus Biosciences
7.15.1 Locus Biosciences Corporate Summary
7.15.2 Locus Biosciences Business Overview
7.15.3 Locus Biosciences CRISPR Gene Testing and Diagnostics Major Product Offerings
7.15.4 Locus Biosciences CRISPR Gene Testing and Diagnostics Revenue in Global Market (2020-2025)
7.15.5 Locus Biosciences Key News & Latest Developments
7.16 Mammoth Biosciences
7.16.1 Mammoth Biosciences Corporate Summary
7.16.2 Mammoth Biosciences Business Overview
7.16.3 Mammoth Biosciences CRISPR Gene Testing and Diagnostics Major Product Offerings
7.16.4 Mammoth Biosciences CRISPR Gene Testing and Diagnostics Revenue in Global Market (2020-2025)
7.16.5 Mammoth Biosciences Key News & Latest Developments
7.17 NRGene
7.17.1 NRGene Corporate Summary
7.17.2 NRGene Business Overview
7.17.3 NRGene CRISPR Gene Testing and Diagnostics Major Product Offerings
7.17.4 NRGene CRISPR Gene Testing and Diagnostics Revenue in Global Market (2020-2025)
7.17.5 NRGene Key News & Latest Developments
7.18 Roche
7.18.1 Roche Corporate Summary
7.18.2 Roche Business Overview
7.18.3 Roche CRISPR Gene Testing and Diagnostics Major Product Offerings
7.18.4 Roche CRISPR Gene Testing and Diagnostics Revenue in Global Market (2020-2025)
7.18.5 Roche Key News & Latest Developments
7.19 Sherlock Biosciences
7.19.1 Sherlock Biosciences Corporate Summary
7.19.2 Sherlock Biosciences Business Overview
7.19.3 Sherlock Biosciences CRISPR Gene Testing and Diagnostics Major Product Offerings
7.19.4 Sherlock Biosciences CRISPR Gene Testing and Diagnostics Revenue in Global Market (2020-2025)
7.19.5 Sherlock Biosciences Key News & Latest Developments
7.20 Thermo Fisher Scientific
7.20.1 Thermo Fisher Scientific Corporate Summary
7.20.2 Thermo Fisher Scientific Business Overview
7.20.3 Thermo Fisher Scientific CRISPR Gene Testing and Diagnostics Major Product Offerings
7.20.4 Thermo Fisher Scientific CRISPR Gene Testing and Diagnostics Revenue in Global Market (2020-2025)
7.20.5 Thermo Fisher Scientific Key News & Latest Developments
7.21 Vivlion
7.21.1 Vivlion Corporate Summary
7.21.2 Vivlion Business Overview
7.21.3 Vivlion CRISPR Gene Testing and Diagnostics Major Product Offerings
7.21.4 Vivlion CRISPR Gene Testing and Diagnostics Revenue in Global Market (2020-2025)
7.21.5 Vivlion Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. CRISPR Gene Testing and Diagnostics Market Opportunities & Trends in Global Market
Table 2. CRISPR Gene Testing and Diagnostics Market Drivers in Global Market
Table 3. CRISPR Gene Testing and Diagnostics Market Restraints in Global Market
Table 4. Key Players of CRISPR Gene Testing and Diagnostics in Global Market
Table 5. Top CRISPR Gene Testing and Diagnostics Players in Global Market, Ranking by Revenue (2024)
Table 6. Global CRISPR Gene Testing and Diagnostics Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global CRISPR Gene Testing and Diagnostics Revenue Share by Companies, 2020-2025
Table 8. Global Companies CRISPR Gene Testing and Diagnostics Product Type
Table 9. List of Global Tier 1 CRISPR Gene Testing and Diagnostics Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CRISPR Gene Testing and Diagnostics Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global CRISPR Gene Testing and Diagnostics Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global CRISPR Gene Testing and Diagnostics Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2026-2032
Table 30. 10x Genomics Corporate Summary
Table 31. 10x Genomics CRISPR Gene Testing and Diagnostics Product Offerings
Table 32. 10x Genomics CRISPR Gene Testing and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 33. 10x Genomics Key News & Latest Developments
Table 34. Aelian Biotechnology Corporate Summary
Table 35. Aelian Biotechnology CRISPR Gene Testing and Diagnostics Product Offerings
Table 36. Aelian Biotechnology CRISPR Gene Testing and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 37. Aelian Biotechnology Key News & Latest Developments
Table 38. Agilent Technologies Corporate Summary
Table 39. Agilent Technologies CRISPR Gene Testing and Diagnostics Product Offerings
Table 40. Agilent Technologies CRISPR Gene Testing and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 41. Agilent Technologies Key News & Latest Developments
Table 42. Axxam Corporate Summary
Table 43. Axxam CRISPR Gene Testing and Diagnostics Product Offerings
Table 44. Axxam CRISPR Gene Testing and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 45. Axxam Key News & Latest Developments
Table 46. Beckman Coulter Corporate Summary
Table 47. Beckman Coulter CRISPR Gene Testing and Diagnostics Product Offerings
Table 48. Beckman Coulter CRISPR Gene Testing and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 49. Beckman Coulter Key News & Latest Developments
Table 50. Becton, Dickinson and Company Corporate Summary
Table 51. Becton, Dickinson and Company CRISPR Gene Testing and Diagnostics Product Offerings
Table 52. Becton, Dickinson and Company CRISPR Gene Testing and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 53. Becton, Dickinson and Company Key News & Latest Developments
Table 54. Binx Health Corporate Summary
Table 55. Binx Health CRISPR Gene Testing and Diagnostics Product Offerings
Table 56. Binx Health CRISPR Gene Testing and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 57. Binx Health Key News & Latest Developments
Table 58. bioM�rieux Corporate Summary
Table 59. bioM�rieux CRISPR Gene Testing and Diagnostics Product Offerings
Table 60. bioM�rieux CRISPR Gene Testing and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 61. bioM�rieux Key News & Latest Developments
Table 62. Bio-Rad Laboratories Corporate Summary
Table 63. Bio-Rad Laboratories CRISPR Gene Testing and Diagnostics Product Offerings
Table 64. Bio-Rad Laboratories CRISPR Gene Testing and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 65. Bio-Rad Laboratories Key News & Latest Developments
Table 66. Caspr Biotech Corporate Summary
Table 67. Caspr Biotech CRISPR Gene Testing and Diagnostics Product Offerings
Table 68. Caspr Biotech CRISPR Gene Testing and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 69. Caspr Biotech Key News & Latest Developments
Table 70. ERS Genomics Corporate Summary
Table 71. ERS Genomics CRISPR Gene Testing and Diagnostics Product Offerings
Table 72. ERS Genomics CRISPR Gene Testing and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 73. ERS Genomics Key News & Latest Developments
Table 74. FASMAC Corporate Summary
Table 75. FASMAC CRISPR Gene Testing and Diagnostics Product Offerings
Table 76. FASMAC CRISPR Gene Testing and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 77. FASMAC Key News & Latest Developments
Table 78. Illumina Corporate Summary
Table 79. Illumina CRISPR Gene Testing and Diagnostics Product Offerings
Table 80. Illumina CRISPR Gene Testing and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 81. Illumina Key News & Latest Developments
Table 82. Janssen Diagnostics Corporate Summary
Table 83. Janssen Diagnostics CRISPR Gene Testing and Diagnostics Product Offerings
Table 84. Janssen Diagnostics CRISPR Gene Testing and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 85. Janssen Diagnostics Key News & Latest Developments
Table 86. Locus Biosciences Corporate Summary
Table 87. Locus Biosciences CRISPR Gene Testing and Diagnostics Product Offerings
Table 88. Locus Biosciences CRISPR Gene Testing and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 89. Locus Biosciences Key News & Latest Developments
Table 90. Mammoth Biosciences Corporate Summary
Table 91. Mammoth Biosciences CRISPR Gene Testing and Diagnostics Product Offerings
Table 92. Mammoth Biosciences CRISPR Gene Testing and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 93. Mammoth Biosciences Key News & Latest Developments
Table 94. NRGene Corporate Summary
Table 95. NRGene CRISPR Gene Testing and Diagnostics Product Offerings
Table 96. NRGene CRISPR Gene Testing and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 97. NRGene Key News & Latest Developments
Table 98. Roche Corporate Summary
Table 99. Roche CRISPR Gene Testing and Diagnostics Product Offerings
Table 100. Roche CRISPR Gene Testing and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 101. Roche Key News & Latest Developments
Table 102. Sherlock Biosciences Corporate Summary
Table 103. Sherlock Biosciences CRISPR Gene Testing and Diagnostics Product Offerings
Table 104. Sherlock Biosciences CRISPR Gene Testing and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 105. Sherlock Biosciences Key News & Latest Developments
Table 106. Thermo Fisher Scientific Corporate Summary
Table 107. Thermo Fisher Scientific CRISPR Gene Testing and Diagnostics Product Offerings
Table 108. Thermo Fisher Scientific CRISPR Gene Testing and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 109. Thermo Fisher Scientific Key News & Latest Developments
Table 110. Vivlion Corporate Summary
Table 111. Vivlion CRISPR Gene Testing and Diagnostics Product Offerings
Table 112. Vivlion CRISPR Gene Testing and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 113. Vivlion Key News & Latest Developments
List of Figures
Figure 1. CRISPR Gene Testing and Diagnostics Product Picture
Figure 2. CRISPR Gene Testing and Diagnostics Segment by Type in 2024
Figure 3. CRISPR Gene Testing and Diagnostics Segment by Application in 2024
Figure 4. Global CRISPR Gene Testing and Diagnostics Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global CRISPR Gene Testing and Diagnostics Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global CRISPR Gene Testing and Diagnostics Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by CRISPR Gene Testing and Diagnostics Revenue in 2024
Figure 9. Segmentation by Type � Global CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global CRISPR Gene Testing and Diagnostics Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global CRISPR Gene Testing and Diagnostics Revenue Market Share, 2020-2032
Figure 13. By Region - Global CRISPR Gene Testing and Diagnostics Revenue Market Share, 2020-2032
Figure 14. By Country - North America CRISPR Gene Testing and Diagnostics Revenue Market Share, 2020-2032
Figure 15. United States CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 16. Canada CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe CRISPR Gene Testing and Diagnostics Revenue Market Share, 2020-2032
Figure 19. Germany CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 20. France CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 22. Italy CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 23. Russia CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia CRISPR Gene Testing and Diagnostics Revenue Market Share, 2020-2032
Figure 27. China CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 28. Japan CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 31. India CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America CRISPR Gene Testing and Diagnostics Revenue Market Share, 2020-2032
Figure 33. Brazil CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa CRISPR Gene Testing and Diagnostics Revenue Market Share, 2020-2032
Figure 36. Turkey CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 37. Israel CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 39. UAE CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 40. 10x Genomics CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Aelian Biotechnology CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Agilent Technologies CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Axxam CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Beckman Coulter CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Becton, Dickinson and Company CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Binx Health CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. bioM�rieux CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Bio-Rad Laboratories CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Caspr Biotech CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 50. ERS Genomics CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 51. FASMAC CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 52. Illumina CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 53. Janssen Diagnostics CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 54. Locus Biosciences CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 55. Mammoth Biosciences CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 56. NRGene CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 57. Roche CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 58. Sherlock Biosciences CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 59. Thermo Fisher Scientific CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 60. Vivlion CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
